Given Tight U.S. Economy, Science Leaders Consider FY 1995 R&D Budget Satisfactory

They say the proposal may be the best they can get, but Rep. George Brown warns that it may not get through Congress intact Officials at major scientific societies and associations say they are generally satisfied with the Clinton administration's $71 billion budget request for science research and development in the 1995 fiscal year. The proposed funding levels, they contend, are about as favorable for the research community as cou

Written byBarton Reppert
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

But Rep. George E. Brown, Jr. (D-Calif.), chairman of the House Science, Space, and Technology Committee--and regarded widely as Congress' No. 1 science expert--has expressed serious concern over the proposals and how they are likely to fare at the hands of his colleagues on Capitol Hill.

The budget, released early last month, includes a 6 percent increase for the National Science Foundation, up to a level of $3.2 billion next year, and a 4.7 percent increase for the National Institutes of Health, up to $10.994 billion in fiscal 1995, beginning on October 1.

Albert H. Teich, director of science and policy programs at the American Association for the Advancement of Science, observes that "the budget is consistent with what the administration has stated its priorities are. They're essentially putting their money where their mouth is."

Teich adds that, "considering the overall state of federal finances and the caps on discretionary ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo
Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery